Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 3815-3821

  Richardson, Max W ^a   Jadlowsky, Julie ^a   Didigu, Chuka A ^a   Doms, Robert W ^a   Riley, James L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CCR5; KRUPPEL LIKE FACTOR 2; SMALL INTERFERING RNA;

ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION SENSITIVITY; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; T LYMPHOCYTE ACTIVATION; VIRUS STRAIN;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; DOWN-REGULATION; DRUG DELIVERY SYSTEMS; G0 PHASE; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOCYTE ACTIVATION; PRIMARY CELL CULTURE; PROTEIN BINDING; RECEPTORS, CCR5; RNA, SMALL INTERFERING;

EID: 84867305632     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201431     Document Type: Article

References (47)

1. Rowland-Jones, S., S. Pinheiro, and R. Kaul. 2001. New insights into host factors in HIV-1 pathogenesis. Cell 104: 473-476. (Pubitemid 32201944)
2. Wu, L., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185: 1681-1691. (Pubitemid 27203264)
3. Ward, S. G., K. Bacon, and J. Westwick. 1998. Chemokines and T lymphocytes: more than an attraction. Immunity 9: 1-11. (Pubitemid 28361290)
4. Creson, J. R., A. A. Lin, Q. Li, D. F. Broad, M. R. Roberts, and S. J. Anderson. 1999. The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro. J. Virol. 73: 9337-9347. (Pubitemid 29487089)
5. Carroll, R. G., J. L. Riley, B. L. Levine, Y. Feng, S. Kaushal, D. W. Ritchey, W. Bernstein, O. S. Weislow, C. R. Brown, E. A. Berger, et al. 1997. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. Science 276: 273-276. (Pubitemid 27172689)
6. Levine, B. L., J. D. Mosca, J. L. Riley, R. G. Carroll, M. T. Vahey, L. L. Jagodzinski, K. F. Wagner, D. L. Mayers, D. S. Burke, O. S. Weislow, et al. 1996. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272: 1939-1943. (Pubitemid 26234505)
7. Arenzana-Seisdedos, F., and M. Parmentier. 2006. Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands. Semin. Immunol. 18: 387-403. (Pubitemid 44511884)
8. Mummidi, S., L. M. Adams, S. E. VanCompernolle, M. Kalkonde, J. F. Camargo, H. Kulkarni, A. S. Bellinger, G. Bonello, H. Tagoh, S. S. Ahuja, et al. 2007. Production of specific mRNA transcripts, usage of an alternate promoter, and octamer-binding transcription factors influence the surface expression levels of the HIV coreceptor CCR5 on primary T cells. J. Immunol. 178: 5668-5681. (Pubitemid 46674363)
9. Mummidi, S., S. S. Ahuja, B. L. McDaniel, and S. K. Ahuja. 1997. The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J. Biol. Chem. 272: 30662-30671. (Pubitemid 27527498)
10. Liu, R., X. Zhao, T. A. Gurney, and N. R. Landau. 1998. Functional analysis of the proximal CCR5 promoter. AIDS Res. Hum. Retroviruses 14: 1509-1519. (Pubitemid 28527795)
11. Kuipers, H. F., P. J. Biesta, L. J. Montagne, E. S. van Haastert, P. van der Valk, and P. J. van den Elsen. 2008. CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor. Blood 112: 1610-1619.
12. Guignard, F., C. Combadiere, H. L. Tiffany, and P. M. Murphy. 1998. Gene organization and promoter function for CC chemokine receptor 5 (CCR5). J. Immunol. 160: 985-992. (Pubitemid 28049344)
13. Mummidi, S., M. Bamshad, S. S. Ahuja, E. Gonzalez, P. M. Feuillet, K. Begum, M. C. Galvis, V. Kostecki, A. J. Valente, K. K. Murthy, et al. 2000. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J. Biol. Chem. 275: 18946-18961. (Pubitemid 30422860)
14. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1997. Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J. Immunol. 159: 5441-5449. (Pubitemid 127470071)
15. Moriuchi, M., and H. Moriuchi. 2001. Octamer transcription factors up-regulate the expression of CCR5, a coreceptor for HIV-1 entry. J. Biol. Chem. 276: 8639-8642.
16. Moriuchi, M., and H. Moriuchi. 2003. YY1 transcription factor down-regulates expression of CCR5, a major coreceptor for HIV-1. J. Biol. Chem. 278: 13003-13007. (Pubitemid 36800067)
17. Moriuchi, M., H. Moriuchi, and A. S. Fauci. 1999. GATA-1 transcription factor transactivates the promoter for CCR5, a coreceptor for human immunodeficiency virus type 1 entry. Blood 93: 1433-1435. (Pubitemid 29076162)
18. Hart, G. T., K. A. Hogquist, and S. C. Jameson. 2012. Krüppel-like factors in lymphocyte biology. J. Immunol. 188: 521-526.
19. Kuo, C. T., M. L. Veselits, and J. M. Leiden. 1997. LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science 277: 1986-1990. (Pubitemid 27449139)
20. Buckley, A. F., C. T. Kuo, and J. M. Leiden. 2001. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat. Immunol. 2: 698-704. (Pubitemid 32747158)
21. Carlson, C. M., B. T. Endrizzi, J. Wu, X. Ding, M. A. Weinreich, E. R. Walsh, M. A. Wani, J. B. Lingrel, K. A. Hogquist, and S. C. Jameson. 2006. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442: 299-302. (Pubitemid 44114904)
22. Bai, A., H. Hu, M. Yeung, and J. Chen. 2007. Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J. Immunol. 178: 7632-7639. (Pubitemid 46898033)
23. Sebzda, E., Z. Zou, J. S. Lee, T. Wang, and M. L. Kahn. 2008. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat. Immunol. 9: 292-300. (Pubitemid 351267326)
24. Weinreich, M. A., K. Takada, C. Skon, S. L. Reiner, S. C. Jameson, and K. A. Hogquist. 2009. KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 31: 122-130.
25. Richardson, M. W., R. G. Carroll, M. Stremlau, N. Korokhov, L. M. Humeau, G. Silvestri, J. Sodroski, and J. L. Riley. 2008. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J. Virol. 82: 11117-11128.
26. Plesa, G., L. Zheng, A. Medvec, C. B. Wilson, C. Robles-Oteiza, N. Liddy, A. D. Bennett, J. Gavarret, A. Vuidepot, Y. Zhao, et al. 2012. TCR affinity and specificity requirements for human regulatory T-cell function. Blood 119: 3420-3430.
27. Riley, J. L., K. Schlienger, P. J. Blair, B. Carreno, N. Craighead, D. Kim, R. G. Carroll, and C. H. June. 2000. Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule. J. Exp. Med. 191: 1987-1997. (Pubitemid 30390360)
28. Riley, J. L., M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B. P. Gregson, C. H. June, and P. S. Linsley. 2002. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA 99: 11790-11795. (Pubitemid 34994477)
29. Funderburg, N. T., J. K. Jadlowsky, M. M. Lederman, Z. Feng, A. Weinberg, and S. F. Sieg. 2011. The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signalling patterns in human monocytes. Immunology 134: 151-160.
30. Cavrois, M., J. Neidleman, M. Bigos, and W. C. Greene. 2004. Fluorescence resonance energy transfer-based HIV-1 virion fusion assay. Methods Mol. Biol. 263: 333-344.
31. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.
32. Carroll, R. G., J. L. Riley, B. L. Levine, P. J. Blair, D. C. St Louis, and C. H. June. 1998. The role of co-stimulation in regulation of chemokine receptor expression and HIV-1 infection in primary T lymphocytes. Semin. Immunol. 10: 195-202. (Pubitemid 28347036)
33. Riley, J. L., B. L. Levine, N. Craighead, T. Francomano, D. Kim, R. G. Carroll, and C. H. June. 1998. Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis. J. Virol. 72: 8273-8280. (Pubitemid 28421825)
34. Levine, B. L., W. B. Bernstein, M. Connors, N. Craighead, T. Lindsten, C. B. Thompson, and C. H. June. 1997. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159: 5921-5930. (Pubitemid 127471527)
35. Wan, Q., L. Kozhaya, A. ElHed, R. Ramesh, T. J. Carlson, I. M. Djuretic, M. S. Sundrud, and D. Unutmaz. 2011. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells. J. Exp. Med. 208: 1875-1887.
36. Mack, M., B. Luckow, P. J. Nelson, J. Cihak, G. Simmons, P. R. Clapham, N. Signoret, M. Marsh, M. Stangassinger, F. Borlat, et al. 1998. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 187: 1215-1224. (Pubitemid 28189111)
37. Riley, J. L., R. G. Carroll, B. L. Levine, W. Bernstein, D. C. St Louis, O. S. Weislow, and C. H. June. 1997. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J. Immunol. 158: 5545-5553. (Pubitemid 127681265)
38. Levine, B. L., W. B. Bernstein, N. E. Aronson, K. Schlienger, J. Cotte, S. Perfetto, M. J. Humphries, S. Ratto-Kim, D. L. Birx, C. Steffens, et al. 2002. Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat. Med. 8: 47-53. (Pubitemid 34101728)
39. Wu, J., and J. B. Lingrel. 2004. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 23: 8088-8096. (Pubitemid 39531849)
40. June, C. H., B. R. Blazar, and J. L. Riley. 2009. Engineering lymphocyte subsets: tools, trials and tribulations. Nat. Rev. Immunol. 9: 704-716.
41. Schober, S. L., C. T. Kuo, K. S. Schluns, L. Lefrancois, J. M. Leiden, and S. C. Jameson. 1999. Expression of the transcription factor lung Krüppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J. Immunol. 163: 3662-3667. (Pubitemid 29450887)
42. Finlay, D., and D. Cantrell. 2010. Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Ann. N Y Acad. Sci. 1183: 149-157.
43. Hart, G. T., X. Wang, K. A. Hogquist, and S. C. Jameson. 2011. Krüppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression. Proc. Natl. Acad. Sci. USA 108: 716-721.
44. Li, Z., Y. Zhang, Z. Liu, X. Wu, Y. Zheng, Z. Tao, K. Mao, J. Wang, G. Lin, L. Tian, et al. 2011. ECM1 controls T(H)2 cell egress from lymph nodes through re-expression of S1P(1). Nat. Immunol. 12: 178-185.
45. Winkelmann, R., L. Sandrock, M. Porstner, E. Roth, M. Mathews, E. Hobeika, M. Reth, M. L. Kahn, W. Schuh, and H. M. Jäck. 2011. B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2. Proc. Natl. Acad. Sci. USA 108: 710-715.
46. Kaufmann, D. E., and B. D. Walker. 2009. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J. Immunol. 182: 5891-5897.
47. Kroetz, D. N., and G. S. Deepe, Jr. 2011. An aberrant thymus in CCR5-/- mice is coupled with an enhanced adaptive immune response in fungal infection. J. Immunol. 186: 5949-5955.